CARDSUP - SWISS Circulatory Support Registry
Recruiting now
Conditions studied: Cardiogenic Shock
In brief
The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing ECMO or Impella implantation at all included sites. All patients undergoing ECMO and/or IMPELLA implantation will be prospectively registered. Device use is according to the decision of the treating physician and independent of this registry.
Key facts
- Study ID
- NCT04117230
- Run by
- Insel Gruppe AG, University Hospital Bern
- People needed
- 1500
- Starts
- 2019-08-09
- Expected to finish
- 2034-08-31
- Last updated by the study team
- 2024-12-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age > 18 years
- Medical indication for implantation of a peripheral cannulated VA-ECMO or microaxial flow pump (IMPELLA) or newer LV / LA-Ascending Aorta devices.
- Signed informed consent by patient or relative or waived consent by EC
You may not qualify if…
- None
Where it is running
- Universitätsspital Basel — Basel, Switzerland (enrolling)
- Insel Gruppe AG, Inselspital Bern — Bern, Switzerland (enrolling)
- Luzerner Kantonsspital — Lucerne, Switzerland (enrolling)
- Kantonsspital Winterthur — Winterthur, Switzerland (enrolling)
- Stadtspital Treimli — Zurich, Switzerland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.